Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
11/2009
11/11/2009CN101574084A 螺二氢吲哚哌啶衍生物 Spiroindoline piperidine derivative
11/10/2009US7615568 3-[2-(cis-4-aminocyclohexyloxy)-4-methylsulfonylbenzoyl-amino]-N-(5-chloropyridin-2-yl)pyridine-2-carboxamide,; anticoagulant; platelet glycoprotein receptor antagonist; thrombosis; orally; acylation of amino-pyridine by (methylthio)benzoic acid followed by oxidation, alkylation, carbonylation
11/10/2009US7615566 Substituted pyrrolidine and related compounds
11/10/2009US7615557 Such as 1-(2-Chlorophenyl)-N-(7-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl)piperidine-4-carboxamide; vanilloid receptor antagonists; urological disorders; inflammation; urinary incontinence; benign prostatic hyperplasia
11/10/2009US7615553 E.g., N,N-dimethyl,((5-(hydroxyaminocarbonyl)pyrimidin-2-yl)(piperazin-1,4-ylene)sulfonamide; bioavailability; oral administration; metabolic stability; side effect reduction; psoriasis; anticarcinogenic -proliferative, -arthritic, -inflammatory agent; gene therapy; genetic transcription potentiation
11/10/2009US7615550 Such as 1-(4-{[1-(1-methylethyl)-4-piperidinyl]oxy}phenyl)-4-{[4-(methylsulfonyl)phenyl]carbonyl}piperazine; neurodegenerative disorders including Alzheimer's disease; allergic rhinitis
11/10/2009CA2410862C Factor viia inhibitory (thio)urea derivatives, their preparation and their use
11/10/2009CA2401637C N-(heterocyclyl)benzene- or - pyridinesulphonamides as antithrombotic and anticoagulant agents
11/10/2009CA2398423C Corrosion inhibiting compositions
11/10/2009CA2382117C 4-substituted piperidine compound
11/10/2009CA2371213C Inhibitors of carboxypeptidase u
11/10/2009CA2353460C Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds
11/05/2009WO2009133778A1 Method for the production of tert-butyl 3-aminopiperidine-1-carboxylate, and intermediates thereof
11/05/2009WO2009133522A1 Piperidine and pyrrolidine compounds
11/05/2009WO2009133180A1 Nicardipine hydrochloride dihydrate and chloroformate
11/05/2009WO2009102460A3 Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/05/2009WO2009077844A3 Inhibitors of biofilm formation of gram-positive and gram-negative bacteria
11/05/2009WO2008075040A3 Radioactive pet agents for imaging ccr5 in vivo
11/05/2009WO2008045015A8 Imino and amino sugar purification
11/05/2009US20090275614 Methylphenidate Derivatives and Uses of Them
11/05/2009US20090275581 Renin inhibitors
11/05/2009US20090275556 Aryl sulfonamides useful as inhibitors of chemokine receptor activity
11/05/2009US20090275554 Aminocarboxylic acid derivative and medicinal use thereof
11/05/2009US20090275535 Antiviral phosphonate analogs
11/05/2009US20090274624 Radiotracers for imaging p-glycoprotein function
11/05/2009CA2722347A1 Piperidine and pyrrolidine compounds
11/04/2009EP2112880A2 Acyl bipiperidinyl compounds, compositions containing such compounds and methods of treatment
11/04/2009EP1784388B1 Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
11/04/2009EP1723140B1 Process for the preparation of tryptase inhibitors
11/04/2009EP1339684B1 Mch antagonists and their use in the treatment of obesity
11/04/2009EP1303488B1 Piperidine compounds for use as ccr-3 inhibitors
11/04/2009CN101570517A 1-(4-benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives
11/03/2009US7612105 3-arylphenyl sulfide derivative and insecticide and miticide
11/03/2009US7612103 Such as 14-O-[4-hydroxy-N-valyl-piperidin-3-yl]-sulfanylacetylmutilin
11/03/2009US7612101 Abnormal cannabidiols as agents for lowering intraocular pressure
11/03/2009US7612095 Polymorph of 4-[2-[4-[1-(2-ethoxyethyl)-1H-benzimidazole-2-yl]-1-piperidinyl]ethyl]-αα-dimethyl-benzeneacetic acid
11/03/2009US7612093 With (-)-2'-deoxy-3'-thiocytidine-5'-triphosphate; immunomodulators; nucleosides
11/03/2009US7612068 (S)-1-{2-[2-(4-Fluoro-phenylsulfanyl)-phenoxy]-ethyl}-pyrrolidine-2-carboxylic acid; glycine transport inhibitors; for schizophrenia and other psychoses
11/03/2009US7612065 Fused n-heterocylic derivatives; mitogen-activated protein kinase inhibitors; Parkinson's disease
11/03/2009US7611696 Block solar radiation; applying to skin, hair
11/03/2009CA2443724C Novel, arylsusfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders
11/03/2009CA2420579C Process for the racemisation of 1-benzyl-4-(4-fluorophenyl)-3-hydroxymethyl-1,2,3,6-tetrahydropyridine to be used as intermediate in the synthesis of paroxetine
11/03/2009CA2318946C Process for the preparation of (-)cis-3-hydroxy-1-methyl-4-(2,4,6-trimethoxyphenyl)piperidine
10/2009
10/29/2009WO2009132136A1 Carboxamide compounds for the treatment of metabolic disorders
10/29/2009WO2009131669A2 Carbamate and urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1
10/29/2009WO2009131096A1 Compound having npy y5 receptor antagonist activity
10/29/2009WO2009131065A1 Long-chain fatty acid elongation enzyme inhibitor comprising arylsulfonyl derivative as active ingredient
10/29/2009WO2009129938A1 Substituted phenoxybenzamides
10/29/2009WO2009039461A3 N-substituted piperidine derivatives as serotonin receptor agents
10/29/2009US20090270629 Process for preparing quaternary salts of piperidyl esters of mandelic acid
10/29/2009US20090270623 Process for production of cinnamide derivative
10/29/2009US20090270451 Piperdine Glycine Transporter Inhibitors
10/29/2009US20090269673 Process for the preparation of compounds containing perfluoroalkanesulfonic acid groups
10/29/2009US20090269278 18F, 11C, or deuterated fluoromethoxy-substituted 4-phenyl-4-benzoylaminomethylpiperindosulfonyl compounds for diagnostic imaging
10/29/2009DE102008020746A1 Verfahren zur Herstellung von quarternären Salzen von Piperidyl Estern der Mandelsäure Process for the preparation of quaternary salts of piperidyl esters of mandelic acid
10/29/2009CA2722139A1 Carboxamide compounds for the treatment of metabolic disorders
10/29/2009CA2722075A1 Long-chain fatty acyl elongase inhibitor comprising arylsulfonyl derivative as active ingredient
10/29/2009CA2721750A1 Carbamate and urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1
10/29/2009CA2721576A1 Compound having npy y5 receptor antagonist activity
10/28/2009EP2112137A1 Method for producing quarternary salts from mandelic acid piperidyl esters
10/28/2009EP1379504B1 Bipiperidinyl-derivatives and their use as chemokine receptors inhibitors
10/28/2009CN101568260A Enantiomer-enriched alpha-,omega amino alcohol derivatives, their production and use as insect- and mite-repelling agents
10/28/2009CN101565409A Piperazidine or homopiperazine oxalyl hydrazine class compound, preparation and use thereof
10/28/2009CN101565397A N-Boc-3-aminopiperidine and synthesizing method of optical isomer thereof
10/28/2009CN100554257C 1-(4-benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives
10/28/2009CN100554253C Process for synthesizing lacidipine of antihypertensive drugs
10/27/2009US7608739 2,3-Dihydrooxadiazoles such as 3-acetyl-5-(2,5-difluorophenyl)-2-phenyl-2,3-dihydro-1,3,4-oxadiazole and 3-[3-acetyl-5-(2,5-difluorophenyl)-2-phenyl-2,3-dihydro-1,3,4-oxadiazol-2-yl]-N,N-dimethylpropan-1-amine that are useful for treating cancer
10/27/2009US7608720 Process for the preparation on 2-aminomethylpyridine derivatives
10/27/2009US7608712 Pyridine imidazoles and aza-indoles as progesterone receptor modulators
10/27/2009US7608639 Such as 3-{4-[3-(4-Chloro-2- phenoxy-phenoxy)- phenoxy]-2-methyl- phenyl}-propionic acid; peroxisome proliferator activated receptor (PPAR); syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, arteriosclerosis
10/27/2009US7608630 Marasmius androsaceus L.es Fr extract, piperidone derivative, and their use for the preparation of hypertensives
10/27/2009US7608629 Useful for the treatment of migraine and other 5-HT1F receptor associated disorders; for example, N-[3-(1-methyl-piperidin-4-yloxy)-phenyl]-2-furancarboxamide
10/27/2009US7608617 N,N-alkylene-6-(piperidin-1-ylalkoxy)naphthalene-2-carboxamide derivatives, e.g., piperidin-1-yl-[6-(3-piperidin-1-yl-propoxy)-naphthalen-2-yl]-methanone and 3,4-dihydro-1H-isoquinolin-2-yl)-[6-(3-piperidin-1-yl-propoxy)-naphthalen-2-yl]-methanone; especially for treating obesity
10/27/2009US7608613 Soluble 17-amino-analogs of geldanamycin in acid addition salt form; water solubility; anticancer agents; storage stability
10/27/2009CA2466724C Benzamide and heteroarylamide as p2x7 receptor antagonists
10/27/2009CA2435426C Process for the preparation of (3-cyano-1h-indol-7-yl)(4-(4-fluorophenethyl)piperazin-1-yl)-methanone and salts thereof
10/27/2009CA2406044C Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use
10/27/2009CA2361285C Propanoic acid derivatives that inhibit the binding of integrins to their receptors
10/27/2009CA2322171C Cyclic amino compounds
10/22/2009WO2009127949A1 4- [3- (aryloxy) benzylidene] -3-methyl piperidine aryl carboxamide compounds useful as faah inhibitors
10/22/2009WO2009127948A1 4- [3- (aryloxy) benzylidene] -3-methyl piperidine 5-membered aryl carboxamide compounds useful as faah inhibitors
10/22/2009WO2009127946A1 4-benzylidene-3-methylpiperidine aryl carboxamide compounds useful as faah inhibitors
10/22/2009WO2009127944A1 Ether benzylidene piperidine aryl carboxamide compounds useful as faah inhibitors
10/22/2009WO2009127943A1 Ether benzylidene piperidine 5-membered aryl carboxamide compounds useful as faah inhibitors
10/22/2009WO2009127338A1 Oxo-heterocyclic substituted carboxylic acid derivates and the use thereof
10/22/2009US20090264657 Stabilization of body-care and household products against degradation by uv radiation using merocyanine derivatives
10/22/2009US20090264469 Novel dicarboxylic acid derivatives
10/22/2009US20090264467 Agents and crystals for improving excretory potency of urinary bladder
10/22/2009US20090264465 Crystalline forms of 4- [2- (4-methylphenylsulfanyl) -phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain
10/22/2009US20090264432 Piperidine and Morpholine Renin Inhibitors
10/22/2009US20090264428 Renin Inhibitors
10/22/2009US20090264414 Amide Derivatives and Pharmaceutical Use Thereof
10/22/2009CA2719789A1 4-benzylidene-3-methylpiperidine aryl carboxamide compounds useful as faah inhibitors
10/22/2009CA2719785A1 Ether benzylidene piperidine aryl carboxamide compounds
10/22/2009CA2719784A1 Ether benzylidene piperidine 5-membered aryl carboxamide compounds
10/22/2009CA2717087A1 4-[3-(aryloxy)benzylidene]-3-methyl piperidine 5-membered aryl carboxamides
10/22/2009CA2716886A1 4-[3-(aryloxy)benzylidene]-3-methyl piperidine aryl carboxamide compounds
10/21/2009EP1979320B1 PIPERAZINES AND PIPERIDINES AS mGluR5 POTENTIATORS
10/21/2009EP1608374B9 2-phenoxy- and 2-phenylsulfomamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
10/21/2009EP1448526B1 Piperidine-based mch antagonists for treatment of obesity and cns disorders
1 ... 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 ... 380